NCT06679803

Brief Summary

The goal of this study is to explore a new intervention that supports physical activity within the first 6 weeks after stroke. All participants will complete assessments at weeks 0 and 7. During weeks 1 through 6, participants will use a Fitbit Inspire to track their step counts and meet with an occupational therapist one time per week. They will also complete weekly surveys. Physical activity levels will be measured using surveys and a wearable activPAL monitor 6 times during the study: Weeks 1, 3, 5, 7, 12, and 24.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
6mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Feb 2025Dec 2026

First Submitted

Initial submission to the registry

November 5, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 8, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

February 5, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

1.6 years

First QC Date

November 5, 2024

Last Update Submit

February 10, 2026

Conditions

Keywords

physical activityoccupational therapybehavioral interventionstroke rehabilitation

Outcome Measures

Primary Outcomes (2)

  • Adherence to PA-ChatS sessions

    Percentage of participants who complete 6 out of 6 (100%) of PA-ChatS sessions. Session completion will be documented by the study intervention therapist and total count of sessions completed will be computed after the last intervention session is delivered.

    6-weeks

  • Adherence to wearable activity tracker

    Percentage of participants who use the wearable activity tracker (Fitbit Inspire 3) an average of 5 of 7 days/week during the 6-week intervention period. Data will be exported from Fitbit to compute average number of days per week the Fitbit was used.

    6-weeks

Secondary Outcomes (8)

  • Acceptability of PA-ChatS Intervention

    Week 7

  • Safety of the PA-ChatS intervention

    Week 7

  • Change in step count

    Weeks 1 to 12

  • Change in sedentary time

    Weeks 1 to 12

  • Adherence to step count

    Week 24

  • +3 more secondary outcomes

Study Arms (1)

PA-ChatS Intervention

EXPERIMENTAL

Participants will receive 6, 20-30 minute intervention sessions delivered over the telephone by an occupational therapist over 6 weeks (1 session/week). They will also complete self-monitoring of step counts using a Fitbit Inspire.

Behavioral: Physical Activity Chats after Stroke (PA-ChatS)

Interventions

PA-ChatS consists of (1) self-monitoring step count using a Fitbit Inspire, and (2) behavioral activation for stepping activity delivered via the telephone and guided by the PA-ChatS workbook. Participants will receive education regarding the physical activity after stroke, American Heart/Stroke Association guidelines for post-stroke physical activity levels, and an overview of the intervention activities. They will then use the Fitbit data to monitor average daily step counts, set a new step count goals (increasing by 5 to 10% of the daily average step count from the prior week), and create a specific plan for achieving the new step count goal. The interventionist will collaboratively problem solve with the participant to identify strategies to overcome barriers to stepping activity and maintain safety.

PA-ChatS Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke diagnosis confirmed by imaging
  • Admitted to Fairview Health System (Minnesota) at the time of study enrollment or discharged to a community-based setting from Fairview Health System within 3 months before study enrollment
  • Able and willing to participate fully in the study and provide informed consent or proxy consent with participant assent

You may not qualify if:

  • Discharge anticipated to a transitional care unit, skilled nursing facility, or other non-community-based care setting
  • Severe cognitive or communication impairments (inability to respond accurately to complete study screening questions or to provide informed consent or assent
  • Comorbid neurological disorder (Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma, spinal cord injury, cerebral palsy)
  • Comorbid cancer, currently undergoing chemotherapy or radiation treatment
  • Received inpatient treatment or was hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
  • Current diagnosis of a terimnal illness and/or receiving hospice care
  • History of allergic reaction to adhesives that precludes the use of an adhesive necessary for adherence to activPAL measurement
  • Inability to speak, read, or understand English
  • Concurrent participation in another rehabilitation intervention research study
  • Resides more than 50 miles outside of the Twin Cities metropolitan area
  • Investigator discretion for safety or adherence reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

StrokeIschemic StrokeHemorrhagic StrokeMotor Activity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavior

Study Officials

  • Emily Kringle, PhD, OTR/L

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2024

First Posted

November 8, 2024

Study Start

February 5, 2025

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Data related to demographics, medical and stroke history, cognitive function, mobility, self-reported psychosocial and social support measures, and physical activity data may be requested.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Deidentified data and supporting documents will be made available upon reasonable request after the main results are published in a peer-reviewed journal.
Access Criteria
Requests for data sharing may be directed to the Principal Investigator. Deidentified IPD and supporting will be provided upon reasonable request through appropriate channels (Data Use Agreement).

Locations